Translational Science by Rejiv Rajendranath
Session 2 : Translational Science
Chairpersons :
Ramesh Nimmagadda, R K Deshpande
Speaker :
Rejiv Rajendranath
PAM50 intrinsic subtype as a predictor of pathological complete response following neoadjuvant dual HER2 blockade without chemotherapy in HER2-positive breast cancer: First results of the PAMELA clinical trial
Author: Prat Aparicio A
Conference: 2016 SABCS S3-03
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Author: Fatima Cardoso
Conference: AACR Abstract CT039 & N Engl J Med2016; 375:717729
Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
Author: Richard Buus
Reference: JNCI J Natl Cancer Inst (2016) 108(11):djw149